ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

2-(Dicyclohexylphosphino)-2'-(dimethylamino)biphenyl → 3-(7,8-dihydro-1,6-naphthyridin-6(5H)-yl)-2-{[(1S,2S)-2-(5-methoxypyridin-2-yl)cyclopropyl]methoxy}-1,5-naphthyridine

HRID 872067
印刷

反応式

HRID 872067 の反応式
Br[C:2]1[C:3]([O:12][CH2:13][C@H:14]2[CH2:16][C@@H:15]2[C:17]2[CH:22]=[CH:21][C:20]([O:23][CH3:24])=[CH:19][N:18]=2)=[N:4][C:5]2[C:10]([CH:11]=1)=[N:9][CH:8]=[CH:7][CH:6]=2.[N:25]1[C:34]2[CH2:33][CH2:32][NH:31][CH2:30][C:29]=2[CH:28]=[CH:27][CH:26]=1.CC(C)([O-])C.[Na+].CN(C1C(C2C(P(C3CCCCC3)C3CCCCC3)=CC=CC=2)=CC=CC=1)C>C1(C)C=CC=CC=1.CCOC(C)=O.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.[Pd].[Pd]>[N:25]1[C:34]2[CH2:33][CH2:32][N:31]([C:2]3[C:3]([O:12][CH2:13][C@H:14]4[CH2:16][C@@H:15]4[C:17]4[CH:22]=[CH:21][C:20]([O:23][CH3:24])=[CH:19][N:18]=4)=[N:4][C:5]4[C:10]([CH:11]=3)=[N:9][CH:8]=[CH:7][CH:6]=4)[CH2:30][C:29]=2[CH:28]=[CH:27][CH:26]=1
参加物反応条件実験手順後処理出典と根拠反応ノート

参加物

8

反応物 4

HCID 27342172-(Dicyclohexylphosphino)-2'-(dimethylamino)biphenylHCID 131938825,6,7,8-Tetrahydro-1,6-naphthyridineHCID 23676156Sodium t-butoxideHCID 1176891283-bromo-2-{[(1S,2S)-2-(5-methoxypyridin-2-yl)cyclopropyl]-methoxy}-1,5-naphthyridine

生成物 1

HCID 1176891403-(7,8-dihydro-1,6-naphthyridin-6(5H)-yl)-2-{[(1S,2S)-2-(5-methoxypyridin-2-yl)cyclopropyl]methoxy}-1,5-naphthyridine

試薬・触媒・溶媒 3

HCID 9811564Bis(dibenzylideneacetone)palladium触媒HCID 1140Toluene溶媒HCID 8857Ethyl Acetate溶媒

反応条件

温度
100 °C

実験手順

A mixture of 3-bromo-2-{[(1S,2S)-2-(5-methoxypyridin-2-yl)cyclopropyl]methoxy}-1,5-naphthyridine (LL1) (25 mg, 0.07 mmol), 5,6,7,8-tetrahydro-1,6-naphthyridine (16.1 mg, 0.08 mmol), sodium t-butoxide (21.8 mg, 0.23 mmol), DavePhos (3.8 mg, 0.009 mmol) and tris(dibenzylideneacetone)dipalladium(0) (4.5 mg, 0.005 mol) in toluene (0.3 mL) was heated at 100° C. for 14 hours. The reaction mixture was allowed to cool to room temperature. The mixture was then diluted with EtOAc (5 mL), washed with sodium bicarbonate (1 mL) and brine (1 mL), dried over MgSO4, filtered and concentrated. The crude residue was purified by reverse phase chromatography (Waters Sunfire Prep C18 OBD, 5-60% acetonitrile in water with 0.1% TFA modifier) to afford the title compound. 1H NMR (500 MHz, DMSO): δ 8.69 (d, J=4.3 Hz, 1 H), 8.38 (d, J=4.8 Hz, 1 H), 8.14 (s, 1 H), 8.06 (d, J=8.3 Hz, 1 H), 7.61-7.53 (m, 2 H), 7.49 (dd, J=8.4, 4.4 Hz, 1 H), 7.27 (s, 2 H), 7.20 (dd, J=7.9, 4.9 Hz, 1 H), 4.63 (dd, J=11.2, 6.4 Hz, 1 H), 4.47-4.36 (m, 3 H), 3.79 (s, 3 H), 3.70-3.59 (m, 2 H), 2.93 (s, 2 H), 2.27-2.23 (m, 1 H), 1.85 (s, 1 H), 1.24 (m, 1 H), 1.12 (dd, J=8.7, 5.4 Hz, 1 H); LRMS m/z (M+H) 440.3 found, 440.2 required.

後処理

  1. temperatureto cool to room temperature
  2. washwashed with sodium bicarbonate (1 mL) and brine (1 mL)
  3. dry with materialdried over MgSO4
  4. filtrationfiltered
  5. concentrationconcentrated
  6. customThe crude residue was purified by reverse phase chromatography (Waters Sunfire Prep C18 OBD, 5-60% acetonitrile in water with 0.1% TFA modifier)

出典と根拠

ORDレコード
ord-70cb3eaee8eb4fd59beef8b93e0c836e
出典データセット
uspto-grants-2015_03
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08975261B2

反応ノート

このページの内容参加物反応条件実験手順後処理出典と根拠反応ノート